Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

12 Months Ended

Nov. 30, 2018

Variables used to determine the fair value of the options granted for the years ended November 30, 2018 and November 30, 2017 are as follows:


	2018			2017
Weighted average values:
Expected dividends		0	%		0	%
Expected volatility		50.85	%		52.07	%
Risk free interest rate		2.67	%		1.82	%
Expected life		5.0 years			5.0 years

Service-Based Vesting Condition Options [Member]

Stock Option Activity

Stock option activity for options with only service-based vesting conditions for the year ended November 30, 2018, was as follows:


				Weighted		Weighted Average
				Average		Remaining		Aggregate
	Options			Exercise Price		Contractual Term (Years)		Intrinsic Value
Outstanding at November 30, 2017		1,026,979		$	2.50		4.48	$	5,706,107
Granted		51,636			7.85				—
Exercised		(63,750	)		2.68				343,935
Expired/forfeited		(13,500	)		2.18				69,450

Outstanding at November 30, 2018		1,001,365			2.77		3.97	$	4,580,967

Exercisable at November 30, 2018		961,111			2.58		3.93	$	4,562,016

Significant Option Groups Outstanding and Exercisable Option and its Price and Contractual Life

Significant option groups outstanding and exercisable at November 30, 2018 and related price and contractual life information are as follows:


	Outstanding						Exercisable
Range of Exercise Prices	Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price
$1.01 to $2.00		422,500		2.93	$	1.73		422,500	$	1.73
$2.01 to $3.00		275,000		2.32	$	2.70		275,000	$	2.70
$3.01 to $4.00		227,229		7.17	$	3.18		223,062	$	3.18
$6.01 to $7.00		25,000		8.34	$	6.95		23,334	$	6.98
$7.01 to $8.00		51,636		5.08	$	7.85		17,215	$	7.85

		1,001,365		3.97	$	2.77		961,111	$	2.58

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of November 30, 2018, and changes during the fiscal year then ended, is presented below:


				Weighted Average
				Grant-Date
	Options			Fair Value
Non-vested at November 30, 2017		39,168		$	2.41
Granted		51,636			3.23
Vested		(50,550	)		2.73
Forfeited		—			—

Non-vested at November 30, 2017		40,254		$	3.06